Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022065
Company: R-PHARM US LLC
Company: R-PHARM US LLC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| IXEMPRA KIT | IXABEPILONE | 15MG/VIAL | INJECTABLE;INTRAVENOUS | Prescription | None | Yes | Yes |
| IXEMPRA KIT | IXABEPILONE | 45MG/VIAL | INJECTABLE;INTRAVENOUS | Prescription | None | Yes | Yes |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 01/11/2023 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022065s013lbl.pdf | |
| 01/21/2022 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022065Orig1s011lbl.pdf | |
| 10/18/2011 | SUPPL-6 | Efficacy-Pediatric | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022065s006lbl.pdf | |
| 05/12/2010 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022065s004s005lbl.pdf | |
| 05/12/2010 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022065s004s005lbl.pdf | |
| 10/02/2009 | SUPPL-3 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022065s002lbl.pdf | |
| 10/02/2009 | SUPPL-2 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022065s002lbl.pdf | |
| 03/13/2009 | SUPPL-1 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022065s001lbl.pdf | |
| 03/13/2009 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022065s001lbl.pdf | |
| 10/16/2007 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022065lbl.pdf |